Decay-Accelerating Factor in Colorectal Cancer
Author Information
Author(s): K. Koretz, S. Briuderlein, C. Henne, P. Moller
Primary Institution: Institute of Pathology, University of Heidelberg, Germany
Hypothesis
The study aims to investigate the expression of decay-accelerating factor (DAF, CD55) in adenomas and colorectal carcinomas.
Conclusion
DAF(CD55) is overexpressed in neoplastic colon epithelia, especially in mucinous carcinoma.
Supporting Evidence
- DAF(CD55) was expressed on the cell surface of all tumor cells in 5 out of 88 colorectal carcinomas.
- DAF(CD55) was found more often in mucinous carcinomas.
- 5 out of 20 adenomas expressed DAF(CD55) on the cell surface of all tumor cells.
Takeaway
This study looked at a protein called DAF that helps cancer cells avoid being attacked by the body's defense system. They found that this protein is more common in certain types of colon cancer.
Methodology
The study used immunohistochemistry to analyze tissue samples from patients with colorectal cancer and adenomas.
Limitations
The study does not establish a correlation between DAF expression and tumor grading or staging.
Participant Demographics
The study included 20 normal colonic tissues, 20 adenomas, and 88 colorectal carcinomas.
Statistical Information
P-Value
0.007
Statistical Significance
p=0.007
Want to read the original?
Access the complete publication on the publisher's website